We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Did you mean cholesterol levels
Information for healthcare professionals on how pulse oximeters are regulated, home use and issues to look out for when using the devices
Find out about the symptoms of COVID-19, what to do if you or your child has them and when to get medical help.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
How to show MHRA you're meeting good clinical practice (GCP) standards and what to expect from an inspection.
Information for clinicians on diagnosis and notification of Shiga toxin-producing Escherichia coli (STEC) and haemolytic uraemic syndrome (HUS).
Statistics on primary school children who are overweight, measured in reception and year 6 and presented for different ethnic groups.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Resources to help local commissioners achieve value for money by estimating the return on investment (ROI) and cost-effectiveness of public health programmes.
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
Data sources of numbers relating to the coronavirus pandemic in the UK.
The review of the safety of isotretinoin has concluded.
Competent authorities of exporting countries should use the relevant model health certificate as a template to create a version exporters can apply for to export gelatine and collagen intended for human consumption to Great Britain, the Channel Islands or Isle...
Background information and advice on coronavirus (COVID-19) for health and care professionals.
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every two months
Find out how to do a rapid lateral flow test for COVID-19. Rapid lateral flow tests show the result on a device that comes with the test.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Advice for medical professionals to follow when assessing drivers with diabetes mellitus.
Guidance for commissioners and health professionals to make decisions about mental health services and interventions based on data and analysis.
You may need to send DVLA a form if you've had a heart attack (myocardial infarction) or heart, cardiac or coronary angioplasty.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.